Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	4 Months Ended	5 Months Ended	9 Months Ended
	Apr. 23, 2021	Sep. 30, 2021	Sep. 30, 2022
Operating activities:
Net loss	$ (1,961,989)	$ (52,475)	$ (50,773)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	92,758	43,885	78,714
Loss on impairment of assets	197,027	0	0
Reorganization items, net	1,587,392
Gain on disposition of assets	(5,486)	(943)	(4,802)
Deferred tax provision	(35,894)	9,122	(7,961)
Stock-based compensation expense		5,822	16,471
Contract liabilities, net	10,617	51,275	(19,725)
Contract assets, net	(742)	(974)	1,330
Deferred contract costs, net	(12,034)	(14,971)	(4,193)
Collateral deposits		4,939	17,479
Other assets, noncurrent	2,685	(72)	(547)
Other liabilities, noncurrent	(371)	(1,354)	(160)
Other	3,158	1,129	1,275
Changes in operating assets and liabilities:
Accounts receivable	2,108	(40,668)	(33,575)
Prepaid expenses and other current assets	(2,791)	2	(979)
Accounts payable and accrued liabilities	29,302	(54,447)	20,884
Taxes payable	(5,804)	8,759	(35,368)
Net cash used in operating activities	(100,064)	(40,971)	(21,930)
Investing activities:
Capital expenditures	(49,119)	(37,845)	(42,653)
Proceeds from disposition of assets, net of disposal costs	7,484	960	5,861
Net cash used in investing activities	(41,635)	(36,885)	(36,792)
Financing activities:
Repayment of borrowings under revolving credit facility	(442,034)
Borrowings on exit facilities	200,000	50,000	69,000
Repayments of exit facilities		(30,000)
Issuance of exit notes	75,000
Principal payments of finance lease liabilities		(6,011)	(11,765)
Debt issuance costs and arrangement fees	(6,218)
Net cash provided by (used in) financing activities	(173,252)	13,989	57,235
Net change in cash, cash equivalents and restricted cash	(314,951)	(63,867)	(1,487)
Cash, cash equivalents and restricted cash, beginning of period	430,380	115,429	62,729
Cash, cash equivalents and restricted cash, end of period	$ 115,429	$ 51,562	$ 61,242